The lymph node ratio predicts cancer-specific survival of node-positive non-small cell lung cancer patients: a population-based SEER analysis

Prognostic value of lymph node ratio after induction therapy in stage IIIA/N2 non-small cell lung cancer: a monocentric clinical study

(2018) Benedikt Haager et al.   Journal of Thoracic Disease

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Lymph-node ratio predicts survival among the different stages of non-small-cell lung cancer: a multicentre analysis†

(2018) Marco Chiappetta et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

Survival Patterns for Patients with Resected N2 Non-Small Cell Lung Cancer and Postoperative Radiotherapy: A Prognostic Scoring Model and Heat Map Approach

(2018) Weiye Deng et al.   Journal of Thoracic Oncology

Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non–Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry

(2017) Wenhua Liang et al.   JOURNAL OF CLINICAL ONCOLOGY

Lymph node ratio as a prognostic factor in patients with pathological N2 non-small cell lung cancer

(2016) Masaya Tamura et al.   World Journal of Surgical Oncology

Lymph node ratio is a prognostic factor for non-small cell lung cancer

(2015) Guangyuan Sun et al.   Oncotarget

Demonstration of the skip metastasis pathway for N2 non–small cell lung cancer

(2014) Hiromitsu Takizawa et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Lymph Node Ratio Predicts Recurrence and Survival After R0 Resection for Non-Small Cell Lung Cancer

(2013) Matthew D. Taylor et al.   ANNALS OF THORACIC SURGERY

Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer

(2013) Raymond U. Osarogiagbon et al.   ANNALS OF THORACIC SURGERY

Prognostic Significance of the Extent of Lymph Node Involvement in Stage II-N1 Non-small Cell Lung Cancer

(2013) Zi-Ming Li et al.   CHEST

Classifications of N2 Non–Small-Cell Lung Cancer Based on the Number and Rate of Metastatic Mediastinal Lymph Nodes

(2013) Masaoki Ito et al.   Clinical Lung Cancer

Validation of the lymph node ratio as a prognostic factor in patients with N1 nonsmall cell lung cancer

(2011) Sirisha Jonnalagadda et al.   CANCER

Video-assisted thoracoscopic indocyanine green fluorescence imaging system shows sentinel lymph nodes in non–small-cell lung cancer

(2010) Shin-ichi Yamashita et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Lymph node ratio as a prognostic factor in elderly patients with pathological N1 non-small cell lung cancer

(2010) J. P. Wisnivesky et al.   THORAX

A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer

(2009) Emilio Bria et al.   LUNG CANCER

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

(2008) Jean-Pierre Pignon et al.   JOURNAL OF CLINICAL ONCOLOGY